DR. MITCHELL BRIN, M.D.
Neurology at Dupont Dr, Irvine, CA
License number
California G86249
Category
Neurology
Type
Neurology
License number
California 142454
Category
Neurology
Type
Neurology
Address
Address
2
2525 Dupont Dr, Irvine, CA 92612
30 San Antonio, Newport Beach, CA 92660
30 San Antonio, Newport Beach, CA 92660
Phone
(714) 246-4429
(714) 242-9099 (Fax)
(714) 242-9099 (Fax)
Personal information
See more information about MITCHELL BRIN at radaris.comName
Address
Phone
324 Sonoma Aisle, Irvine, CA 92618
30 San Antonio, Newport Beach, CA 92660
Organization information
See more information about MITCHELL BRIN at bizstanding.comMitchell Brin MD
2525 Dupont Dr, Irvine, CA 92612
Industry:
Neurologist
Phone:
(714) 246-4613 (Phone), (714) 246-4429 (Phone)
Mitchell Francis Brin
Categories:
Neurology Physicians & Surgeons
Professional information
See more information about MITCHELL BRIN at trustoria.com
Endopeptidase Treatment Of Neuroendocrine Disorders
Endopeptidase Treatment Of Neuroendocrine Disorders
US Patent:
2012025, Oct 4, 2012
Filed:
Mar 20, 2012
Appl. No.:
13/425099
Inventors:
Andrew M. Blumenfeld - Del Mar CA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 39/08, C12N 9/96, A61P 25/00
US Classification:
4242391, 435188
Abstract:
The present specification discloses TEMs, compositions comprising such TEMs, compositions comprising such TEMs and Clostridial toxins, methods of treating a neuroendocrine disorder in an individual using such compositions, use of such TEMs in manufacturing a medicament for treating a neuroendocrine disorder, use of such TEMs and Clostridial toxins in manufacturing a medicament for treating neuroendocrine disorder, use of such TEMs in treating a neuroendocrine disorder, and use of such TEMs and Clostridial toxins in treating a neuroendocrine disorder.
Endopeptidase And Neurotoxin Combination Treatment Of Multiple Medical Conditions
Endopeptidase And Neurotoxin Combination Treatment Of Multiple Medical Conditions
US Patent:
2012025, Oct 4, 2012
Filed:
Mar 20, 2012
Appl. No.:
13/425229
Inventors:
Andrew M. Blumenfeld - Del Mar CA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 39/08, A61P 25/00, A61P 25/06, A61P 25/14
US Classification:
4242391
Abstract:
The present specification discloses Clostridial neurotoxins and TEMs, compositions comprising such Clostridial neurotoxins and TEMs, methods of treating a multiple medical disorder in an individual using such compositions, use of such Clostridial neurotoxins and TEMs in manufacturing a medicament for treating a multiple medical disorder, and uses of such Clostridial neurotoxins and TEMs in treating a multiple medical disorder.
Therapeutic Treatments Using Botulinum Neurotoxin
Therapeutic Treatments Using Botulinum Neurotoxin
US Patent:
2013025, Sep 26, 2013
Filed:
May 22, 2013
Appl. No.:
13/900067
Inventors:
Mitchell F. Brin - Newport Beach CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 38/16
US Classification:
424780
Abstract:
Methods for treating a coronary risk factor (such as hypertension, diabetes, hyperlipidemia and obesity) and/or a respiratory disorder (such as asthma, chronic obstructive pulmonary disease and bronchitis) and/or arthritis by local administration of a botulinum neurotoxin to at least one of a head, neck or shoulder location (for example, by subdermal, subcutaneous or intramuscular administration of the botulinum neurotoxin) of a patient with a coronary risk factor, respiratory disorder or arthritis.
Endopeptidase Treatment Of Involuntary Movement Disorders
Endopeptidase Treatment Of Involuntary Movement Disorders
US Patent:
2012025, Oct 4, 2012
Filed:
Mar 20, 2012
Appl. No.:
13/425253
Inventors:
Andrew M. Blumenfeld - Del Mar CA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 39/08, C12N 9/96, A61P 25/14
US Classification:
4242391, 435188
Abstract:
The present specification discloses TEMs, compositions comprising such TEMs, compositions comprising such TEMs and Clostridial toxins, methods of treating an involuntary movement disorder in an individual using such compositions, use of such TEMs in manufacturing a medicament for treating an involuntary movement disorder, use of such TEMs and Clostridial toxins in manufacturing a medicament for treating an involuntary movement disorder, use of such TEMs in treating an involuntary movement disorder, and use of such TEMs and Clostridial toxins in treating an involuntary movement disorder.
Biodegradable Non-Ophthalmic Implants And Related Methods
Biodegradable Non-Ophthalmic Implants And Related Methods
US Patent:
2013028, Oct 24, 2013
Filed:
Jun 19, 2013
Appl. No.:
13/921931
Inventors:
Mitchell Brin - Newport Beach CA, US
International Classification:
A61K 9/00, A61K 47/32
US Classification:
424426
Abstract:
Biodegradable non-ophthalmic implants include one or more agents dispersed within a biodegradable polymer component. The implants release the agents from the biodegradable polymer component to a target site of a patient as the implant degrades. The agents provided in the implants can be therapeutic agents or diagnostic agents and are useful in medical treatments of non-ocular regions of a patient.
Injection Paradigm For Administration Of Botulinum Toxins
Injection Paradigm For Administration Of Botulinum Toxins
US Patent:
2013033, Dec 12, 2013
Filed:
Apr 16, 2013
Appl. No.:
13/863522
Inventors:
Sheena K. Aurora - Seattle WA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
C07K 14/33
US Classification:
424 9467
Abstract:
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
Methods For Treating Headache
Methods For Treating Headache
US Patent:
2010018, Jul 29, 2010
Filed:
Mar 19, 2010
Appl. No.:
12/727960
Inventors:
Catherine C. Turkel - Newport Coast CA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 49/00, A61P 25/00
US Classification:
424 92
Abstract:
A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.
Methods For Treating Headache
Methods For Treating Headache
US Patent:
7704511, Apr 27, 2010
Filed:
Jan 11, 2006
Appl. No.:
11/329598
Inventors:
Catherine C. Turkel - Newport Coast CA, US
Mitchell F. Brin - Newport Beach CA, US
Mitchell F. Brin - Newport Beach CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 39/02, A61K 39/08, A61K 39/38, A61K 38/00
US Classification:
4242361, 4242391, 4242471, 4242341, 4241841, 512 2
Abstract:
The present invention features methods for selecting a patient with an enhanced therapeutic response to a toxin treatment of a headache. In some embodiments, the methods comprise the step of identifying a patient who is not using a prophylactic headache pain medication, a patient who is overusing an acute pain medication, a patient who suffers four or more hours of headache pain per headache, a patient who has a chronic daily headache for twenty or more years, and/or a patient who has twenty or more headache days out of a 30-day-month.
Methods For Treating Mammary Gland Disorders
Methods For Treating Mammary Gland Disorders
US Patent:
7838007, Nov 23, 2010
Filed:
Feb 8, 2002
Appl. No.:
10/071826
Inventors:
Mitchell F. Brin - Newport Beach CA, US
Stephen Donovan - Capistrano Beach CA, US
Stephen Donovan - Capistrano Beach CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 39/02, A61K 39/00, A61K 39/38, A61K 39/08, A61K 38/00, A01K 37/18
US Classification:
4242361, 4241841, 4242341, 4242391, 4242471, 514 2
Abstract:
A method for treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue.
Methods For Treating Vascular Disorders
Methods For Treating Vascular Disorders
US Patent:
2005015, Jul 14, 2005
Filed:
Jan 8, 2004
Appl. No.:
10/754364
Inventors:
Mitchell Brin - Newport Beach CA, US
Markus Naumann - Kurnach, DE
Markus Naumann - Kurnach, DE
International Classification:
A61K039/08
US Classification:
424239100
Abstract:
Methods for treating vascular disorders by administering a botulinum toxin directly to a blood vessel of a patient.